Skip to main content

The expanding world of RNA therapies

Over the past several years, a number of biotech companies have made strides in constructing small molecule drugs to target RNA. Now genetic messenger molecules power the coronavirus vaccines developed by BioNTech and Moderna, training the body's immune system to detect and defend against disease and infection.

included in this trendline
  • Pfizer, BioNTech bet mRNA can make a better shingles vaccine
  • ProQR eye drug comes up short in key study, surprising company and investors
  • Moderna founder unveils new drug company focused on a different kind of RNA
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.